Category: Peptide Q&A
-
Are there any known contraindications for SLU-PP-332 in individuals with mitochondrial diseases or inherited metabolic disorders?
Are there any known contraindications for SLU-PP-332 in individuals with mitochondrial diseases or inherited metabolic disorders?
-
What biomarkers of mitochondrial dysfunction (e.g., plasma citrate, lactate, mtDNA copy number) show reversal with SLU-PP-332 treatment in human clinical trials?
What biomarkers of mitochondrial dysfunction (e.g., plasma citrate, lactate, mtDNA copy number) show reversal with SLU-PP-332 treatment in human clinica
-
How does SLU-PP-332 compare to coenzyme Q10 in improving mitochondrial respiration in patients with mitochondrial myopathy?
How does SLU-PP-332 compare to coenzyme Q10 in improving mitochondrial respiration in patients with mitochondrial myopathy?
-
What regulatory status does SLU-PP-332 hold in the U.S. (FDA), EU (EMA), or Japan (PMDA), and what are the implications for clinical use?
What regulatory status does SLU-PP-332 hold in the U.S. (FDA), EU (EMA), or Japan (PMDA), and what are the implications for clinical use?
-
In models of ischemic stroke, what time window post-injury allows for effective intervention with SLU-PP-332, and how does it influence infarct size and functional recovery?
In models of ischemic stroke, what time window post-injury allows for effective intervention with SLU-PP-332, and how does it influence infarct size and
-
What peer-reviewed publications have demonstrated SLU-PP-332’s ability to reduce amyloid-beta plaque burden in transgenic Alzheimer’s models?
What peer-reviewed publications have demonstrated SLU-PP-332’s ability to reduce amyloid-beta plaque burden in transgenic Alzheimer’s models?
-
What neuroimaging data (e.g., fMRI, PET) in rodent models demonstrate SLU-PP-332’s impact on cerebral blood flow and metabolic activity in regions associated with memory and executive function?
What neuroimaging data (e.g., fMRI, PET) in rodent models demonstrate SLU-PP-332’s impact on cerebral blood flow and metabolic activity in regions assoc